CVS HEALTH Corp (CVS) Financials
Annual revenue, profitability and per-share results for CVS HEALTH Corp, as reported in SEC filings.
Revenue · FY2025
$402.07B
▲ 7.8%YoY
Net income · FY2025
$1.73B
▼ 62.3%YoY
Diluted EPS · FY2025
$1.39
▼ 62.0%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS |
|---|---|---|---|---|
| FY2025 | $402.07B | $1.73B | — | $1.39 |
| FY2024 | $372.81B | $4.59B | — | $3.66 |
| FY2023 | $357.78B | $8.37B | — | $6.47 |
| FY2022 | $322.47B | $4.17B | — | $3.14 |
Figures as reported in CVS HEALTH Corp's 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a CVS filing.
Get an email when CVS files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.